Table 1 Baseline characteristics of patients
n | 65 |
Age, years | 81.05 ± 7.94 |
Male | 26 (40%) |
CLTI | 65 (100%) |
Ambulatory | 21 (32.3%) |
HT | 61 (93.8) |
DL | 59 (90.8%) |
DM | 48 (73.8%) |
CKD | 21 (32.3%) |
HD | 5 (7.7%) |
Wifi grade | |
1 | 9 (13.8%) |
2 | 15 (23.1%) |
3 | 24 (36.9%) |
4 | 18 (27.7%) |
De novo | 40 (61.5%) |
ATA | 18 (27.7%) |
ATA-DPA | 25 (38.5%) |
PA | 6 (9.2%) |
PTA | 12 (18.5%) |
PTA-PLA | 4 (6.2%) |
FP lesion treated | 22 (34.4%) |
Entry blunt | 36 (55.4%) |
Calcification at entry point | 16 (24.6%) |
PACCS 3/4 | 9 (13.8%) |
Lesion length | 270.1 ± 78.2 |
CTO length | 228.2 ± 93.7 |
RVD | 2.1 ± 0.71 |
Proximal RVD < 2.0 | 36 (55.4%) |
Outflow absent | 25 (38.5%) |
J-BTK CTO | |
0 | 4 (6.2%) |
1 | 8 (12.3%) |
2 | 13 (20.0%) |
3 | 15 (23.1%) |
4 | 17 (26.2%) |
5 | 7 (10.1%) |
6 | 1 (1.5%) |
GLASS FP grade | |
0 | 38 (58.5%) |
1 | 20 (30.8%) |
2 | 2 (3.1%) |
3 | 2 (3.1%) |
4 | 3 (4.6%) |
GLASS IP grade | |
2 | 2 (3.1%) |
3 | 8 (12.3%) |
4 | 55 (84.6%) |
GLASS stage | |
II | 6 (9.2%) |
III | 59 (90.8%) |
Pedal arch | |
P0 | 8 (12.3%) |
P1 | 42 (64.6%) |
P2 | 15 (23.1%) |
Kawarada classification | |
1 | 7 (10.8%) |
2A | 14 (21.5%) |
2B | 27 (41.5%) |
3 | 17 (26.2%) |